🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assess the efficacy of several subcutaneous doses of nemolizumab in moderat...
Status
Completed
Location
Galderma Investigational site
Start Date
2017-06-14
Trial ID
NCT03100344
Treatments Being Tested
The primary objective of this study is to assess the PK/PD relationship of ...
Status
Active Not Recruiting
Location
Galderma Investigational Site (site# 8893)
Start Date
2025-10-20
Trial ID
NCT07074977
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetics and safety o...
Status
Completed
Location
Galderma Investigational Site
Start Date
2019-04-09
Trial ID
NCT03921411
Treatments Being Tested
The main purpose of the study was to assess the efficacy and safety of nemo...
Status
Completed
Location
Galderma Investigational Site 8880
Start Date
2019-06-27
Trial ID
NCT03985943
Treatments Being Tested
Patients ≥ 18 years of age with Lichen sclerosis (LS)...
Status
Not Yet Recruiting
Location
University of Texas Southwestern Medical Center
Start Date
2026-09-01
Trial ID
NCT07704775
Treatments Being Tested
This pilot project intends to examine the utility of a systems medicine app...
Status
Recruiting
Location
Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel
Start Date
2017-01-20
Trial ID
NCT03358693
To assess the safety, tolerability and efficacy of CIM331, compared to plac...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01986933
Treatments Being Tested
The purpose of this study is to evaluate the effect of nemolizumab (CD14152...
Status
Completed
Location
8894 Galderma Investigational Site
Start Date
2021-12-08
Trial ID
NCT04562116
Treatments Being Tested
The purpose of this study is to assess the effect of nemolizumab (CD14152) ...
Status
Completed
Location
Galderma Investigational Site (Site#9922)
Start Date
2020-03-05
Trial ID
NCT04365387
Treatments Being Tested